Anifrolumab in recalcitrant cutaneous dermatomyositis: A multicenter retrospective cohort study

J Am Acad Dermatol. 2024 Aug 12:S0190-9622(24)02609-4. doi: 10.1016/j.jaad.2024.07.1491. Online ahead of print.
No abstract available

Keywords: anifrolumab; dermatomyositis; refractory; type I interferon.